Literature DB >> 6961429

Molecular and cellular pathogenesis of hemoglobin SC disease.

H F Bunn, C T Noguchi, J Hofrichter, G P Schechter, A N Schechter, W A Eaton.   

Abstract

Solution and cell studies were performed to ascertain why individuals with hemoglobin (Hb) SC have disease whereas those with Hb AS do not. The polymerization of deoxygenated mixtures containing sickle cell Hb (Hb S; alpha 2 beta 2(6)Glu leads to Val) and Hb C (alpha 2 beta 2(6)Glu leads to Lys) was investigated by measurements of delay times and solubilities. In mixtures containing more than 40% Hb S, polymerization takes place by the same mechanism as in solutions of Hb S alone, with no evidence for independent crystallization of Hb C. A detailed comparison of Hb S/Hb C and Hb S/Hb A mixtures with identical concentrations and proportions of Hb S show that there is no significant difference in the tendency of Hb C and Hb A to copolymerize with Hb S. In 50:50 Hb S/Hb C mixtures, polymerization is about 15 times more rapid than in 40:60 Hb S/Hb A mixtures at the same total Hb concentration. Measurements on density-fractionated erythrocytes show that SC cells contain a higher total Hb concentration and a more uniform distribution of reticulocytes compared to normal (AA) or sickle trait (AS) cells. The concentration distribution for C trait (AC) cells is much closer to that of SC cells than to AS or AA cells. It appears, therefore, that the presence of Hb C results in the SC cell beginning its life with an abnormally high Hb concentration. From these findings we conclude that both the larger proportion of Hb S and the higher intracellular Hb concentration contribute to the pathogenesis of Hb SC disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6961429      PMCID: PMC347373          DOI: 10.1073/pnas.79.23.7527

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Supersaturation in sickle cell hemoglobin solutions.

Authors:  J Hofrichter; P D Ross; W A Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

2.  Editorial: Delay time of gelation: a possible determinant of clinical severity in sickle cell disease.

Authors:  W A Eaton; J Hofrichter; P D Ross
Journal:  Blood       Date:  1976-04       Impact factor: 22.113

3.  Sickling times of individual erythrocytes at zero Po2.

Authors:  H S Zarkowsky; R M Hochmuth
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

4.  Trimodality in the percentages of beta chain variants in heterozygotes: the effect of the number of active Hbalpha structural loci.

Authors:  T H Huisman
Journal:  Hemoglobin       Date:  1977       Impact factor: 0.849

5.  Genetic model for observed distributions of proportions of haemoglobin in sickle-cell trait.

Authors:  G Brittenham
Journal:  Nature       Date:  1977-08-18       Impact factor: 49.962

6.  Ligand kinetics of hemoglobin S containing erythrocytes.

Authors:  J P Harrington; D Elbaum; R M Bookchin; J B Wittenberg; R L Nagel
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

7.  Separation of erythrocytes according to age on a simplified density gradient.

Authors:  L M Corash; S Piomelli; H C Chen; C Seaman; E Gross
Journal:  J Lab Clin Med       Date:  1974-07

8.  A comparison of erythrocyte characteristics in sickle cell syndromes in Jamaica.

Authors:  G R Serjeant; B E Serjeant
Journal:  Br J Haematol       Date:  1972-08       Impact factor: 6.998

9.  Hemoglobin interaction: modification of solid phase composition in the sickling phenomenon.

Authors:  J F Bertles; R Rabinowitz; J Döbler
Journal:  Science       Date:  1970-07-24       Impact factor: 47.728

10.  Monovalent cation composition and ATP and lipid content of irreversibly sickled cells.

Authors:  M R Clark; R C Unger; S B Shohet
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

View more
  28 in total

1.  A model for the sickle hemoglobin fiber using both mutation sites.

Authors:  A Roufberg; F A Ferrone
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

2.  Hemoglobin sickle cell disease complications: a clinical study of 179 cases.

Authors:  François Lionnet; Nadjib Hammoudi; Katia Stankovic Stojanovic; Virginie Avellino; Gilles Grateau; Robert Girot; Jean-Philippe Haymann
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

3.  The rules of variation: amino acid exchange according to the rotating circular genetic code.

Authors:  Fernando Castro-Chavez
Journal:  J Theor Biol       Date:  2010-04-03       Impact factor: 2.691

4.  Detrimental effects of adenosine signaling in sickle cell disease.

Authors:  Yujin Zhang; Yingbo Dai; Jiaming Wen; Weiru Zhang; Almut Grenz; Hong Sun; Lijian Tao; Guangxiu Lu; Danny C Alexander; Michael V Milburn; Louvenia Carter-Dawson; Dorothy E Lewis; Wenzheng Zhang; Holger K Eltzschig; Rodney E Kellems; Michael R Blackburn; Harinder S Juneja; Yang Xia
Journal:  Nat Med       Date:  2010-12-19       Impact factor: 53.440

5.  Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort study.

Authors:  Tatiana M Lopera-Mesa; Saibou Doumbia; Drissa Konaté; Jennifer M Anderson; Mory Doumbouya; Abdoul S Keita; Seidina A S Diakité; Karim Traoré; Michael A Krause; Ababacar Diouf; Samuel E Moretz; Gregory S Tullo; Kazutoyo Miura; Wenjuan Gu; Michael P Fay; Steve M Taylor; Carole A Long; Mahamadou Diakité; Rick M Fairhurst
Journal:  Lancet Haematol       Date:  2015-03-24       Impact factor: 18.959

6.  Dyspnea with hemoglobin SC disease.

Authors:  Linda S Bang; Robert D Black; Shelley A Hall; William C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-01

7.  Human bulbar conjunctival hemodynamics in hemoglobin SS and SC disease.

Authors:  Justin Wanek; Bruce Gaynes; Jennifer I Lim; Robert Molokie; Mahnaz Shahidi
Journal:  Am J Hematol       Date:  2013-06-12       Impact factor: 10.047

8.  Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations.

Authors:  W N Poillon; B C Kim; G P Rodgers; C T Noguchi; A N Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  Kinetic assay shows that increasing red cell volume could be a treatment for sickle cell disease.

Authors:  Quan Li; Eric R Henry; James Hofrichter; Jeffrey F Smith; Troy Cellmer; Emily B Dunkelberger; Belhu B Metaferia; Stacy Jones-Straehle; Sarah Boutom; Garrott W Christoph; Terri H Wakefield; Mary E Link; Dwayne Staton; Erica R Vass; Jeffery L Miller; Matthew M Hsieh; John F Tisdale; William A Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

10.  Practicing biochemistry without a license.

Authors:  H Franklin Bunn
Journal:  J Biol Chem       Date:  2013-01-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.